Jpmorgan Chase & CO Werewolf Therapeutics, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.51 Trillion
  • Q3 2025

A detailed history of Jpmorgan Chase & CO transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 1,123 shares of HOWL stock, worth $1,055. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,123
Previous 1,123 -0.0%
Holding current value
$1,055
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
SELL
$1.05 - $2.19 $15,633 - $32,606
-14,889 Reduced 92.99%
1,123 $2,000
Q1 2025

May 12, 2025
SELL
$0.97 - $1.68 $45,508 - $78,818
-46,916 Reduced 74.56%
16,012 $15,000
Q4 2024

Feb 12, 2025
BUY
$1.48 - $3.63 $73,419 - $180,077
49,608 Added 372.43%
62,928 $93,000
Q3 2024

Dec 26, 2024
BUY
$1.71 - $2.95 $418 - $722
245 Added 1.87%
13,320 $28,000
Q3 2024

Nov 08, 2024
BUY
$1.71 - $2.95 $418 - $722
245 Added 1.87%
13,320 $28,000
Q2 2024

Dec 26, 2024
SELL
$2.34 - $6.75 $573 - $1,653
-245 Reduced 1.84%
13,075 $31,000
Q2 2024

Aug 12, 2024
SELL
$2.34 - $6.75 $135,975 - $392,235
-58,109 Reduced 81.63%
13,075 $31,000
Q1 2024

Dec 26, 2024
BUY
$3.92 - $7.91 $226,826 - $457,704
57,864 Added 434.41%
71,184 $461,000
Q1 2024

May 10, 2024
BUY
$3.92 - $7.91 $278,715 - $562,408
71,101 Added 85663.86%
71,184 $461,000
Q4 2023

Dec 26, 2024
SELL
$1.78 - $4.15 $23,561 - $54,933
-13,237 Reduced 99.38%
83 $0
Q4 2023

Feb 12, 2024
SELL
$1.78 - $4.15 $1,183 - $2,759
-665 Reduced 88.9%
83 $0
Q4 2022

Feb 13, 2023
SELL
$1.53 - $4.73 $1,150 - $3,556
-752 Reduced 50.13%
748 $2,000
Q3 2022

Nov 14, 2022
SELL
$4.14 - $7.42 $9,099 - $16,309
-2,198 Reduced 59.44%
1,500 $7,000
Q2 2022

Aug 11, 2022
SELL
$3.43 - $5.98 $40,916 - $71,335
-11,929 Reduced 76.34%
3,698 $15,000
Q1 2022

May 11, 2022
SELL
$3.71 - $12.22 $46,115 - $151,894
-12,430 Reduced 44.3%
15,627 $68,000
Q4 2021

Feb 10, 2022
BUY
$11.48 - $17.65 $277,919 - $427,288
24,209 Added 629.13%
28,057 $334,000
Q3 2021

Nov 12, 2021
BUY
$13.89 - $20.31 $53,448 - $78,152
3,848 New
3,848 $66,000

Others Institutions Holding HOWL

# of Institutions
64
Shares Held
22.7M
Call Options Held
0
Put Options Held
0
View Full List

About Werewolf Therapeutics, Inc.

HOWL Quotes by TradingView
  • Ticker HOWL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,529,400
  • Market Cap $27.8M
  • Description
  • Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...
More about HOWL
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email